Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Facebook Roundtable: COVID-19 Vaccines and Cancer Care - The known, the unknown and the unknowable

ESMO-Facebook-Roundtable-Covid-19-Vaccines-and-Cancer-Care-the-known-the-unknown-and-the-unknowabale

Benefits and risks of vaccinating patients with cancer against COVID-19

In this ESMO Live Roundtable, which took place on 22 January 2021, renowed experts in oncology, immunology and vaccinology discussed major issues on immunising patients with cancer against Sars-CoV-2 infection and addressed some uncertainties which still exist in this area.

In the panel

  • Solange Peters, ESMO President, University Hospital of Lausanne, Switzerland
  • Ravindran Kanesvaran, National Cancer Centre Singapore, Singapore
  • Thomas Powles, Barts Cancer Institute, London, UK
  • Leif Erik Sander, Charity University Hospital, Berlin, Germany
  • Uwe Gerd Liebert, Leipzig University Medical Center, Germany

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings